Rare Diseases in Malaysia: Mapping the Landscape and Building a Framework for Comprehensive Care Support
Abozaid, G.M., Kerr, K., McKnight, A., Al-Omar, H.A. 2022. Criteria to define rare diseases and orphan drugs: A systematic review protocol. BMJ Open 12(7): e062126. https://doi.org/10.1136/bmjopen-2022-062126
AHRQ Methods for Effective Health Care. 2014. In: Gliklich, R.E., Dreyer, N.A., Leavy, M.B. (eds.). Registries for Evaluating Patient Outcomes: A User’s Guide. Rockville (MD): Agency for Healthcare Research and Quality (US).
Aizawa, Y., Watanabe, A., Kato, K. 2021. Institutional and social issues surrounding genetic counselors in Japan: Current challenges and implications for the global community. Front Genet 12: 646177. https://doi.org/10.3389/fgene.2021.646177
Amini, F., Kin, W.Y., Kolandaiveloo, L. 2014. Physicians’ knowledge and perception of gene profiling in Malaysia. Int J Med Health Biomed Pharm Eng 8(12): 841–845.
Angelis, A., Aggarwal, A., Miners, A., Grieve, R., Cairns, J., Briggs, A. 2023. The innovative medicines fund: A universal model for faster and fairer access to new promising medicines or a Trojan horse for low-value creep? J R Soc Med 116(10): 324–330. https://doi.org/10.1177/01410768231192476
Benito-Lozano, J., López-Villalba, B., Arias-Merino, G., Posada De La Paz, M., Alonso-Ferreira, V. 2022. Diagnostic delay in rare diseases: Data from the Spanish rare diseases patient registry. Orphanet J Rare Dis 17(1): 418. https://doi.org/10.1186/s13023-022-02530-3
Boycott, K.M., Rath, A., Chong, J.X., Hartley, T., Alkuraya, F.S., Baynam, G., Brookes, A.J., Brudno, M., Carracedo, A., Den Dunnen, J.T., et al. 2017. International cooperation to enable the diagnosis of all rare genetic diseases. Am J Hum Genet 100(5): 695–705. https://doi.org/10.1016/j.ajhg.2017.04.003
Chambers, J.D., Panzer, A.D., Kim, D.D., Margaretos, N.M., Neumann, P.J. 2019. Variation in US private health plans’ coverage of orphan drugs. Am J Manag Care 25(10): 508–512.
Choi, S.A., Lim, K., Baek, H., Yoo, S., Cho, A., Kim, H., Hwang, H., Kim, K.J. 2021. Impact of mobile health application on data collection and self-management of epilepsy. Epilepsy Behav 119: 107982. https://doi.org/10.1016/j.yebeh.2021.107982
Chua, H.T., Cheah, J.C. 2012. Financing universal coverage in Malaysia: A case study. BMC Public Health 12(Suppl 1): S7. https://doi.org/10.1186/1471-2458-12-S1-S7
Chung, C.C.Y., Chu, A.T.W., Chung, B.H.Y. 2022. Rare disease emerging as a global public health priority. Front Public Health 10: 1028545. https://doi.org/10.3389/fpubh.2022.1028545
Conduah, A.K., Ofoe, S., Siaw-Marfo, D. 2025. Data privacy in healthcare: Global challenges and solutions. Digit Health 11: 20552076251343959. https://doi.org/10.1177/20552076251343959
Drell, D., De Silva, A., Lee, C. 2022. What rare disease patient advocacy groups are doing to mitigate the effects of disparities. Adv Pulm Hypertens 21(2): 35–43. https://doi.org/10.21693/1933088X-21.2.35
Elsalti, A., Darkhabani, M., Alrifaai, M.A., Mahroum, N. 2023. Celebrities and medical awareness: The case of Celine Dion and stiff-person syndrome. Int J Environ Res Public Health 20(3): 1936. https://doi.org/10.3390/ijerph20031936
Farhani, S., Roslina, A.J., Nik Mazlina, M., Noor Hasliza, H., Lih Bing, L., Noorul Amilin, S., Zienna Zufida, Z.R., Siti Khalimah, R. 2024. Utilisation of the web-based Home Assessment Tool among patients with COVID-19 in Selangor, Malaysia: An observational study. Malays Fam Physician 19: 19. https://doi.org/10.51866/oa.205
Faye, F., Crocione, C., Anido De Peña, R., Bellagambi, S., Escati Peñaloza, L., Hunter, A., Jensen, L., Oosterwijk, C., Schoeters, E., De Vicente, D., Faivre, L., Wilbur, M., Le Cam, Y., Dubief, J. 2024. Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: Results of a Rare Barometer retrospective patient survey. Eur J Hum Genet 32(9): 1116–1126. https://doi.org/10.1038/s41431-024-01604-z
Gong, L., He, Q. 2021. Establishing a rare diseases center: Experiences from Western China. Intractable Rare Dis Res 10(1): 60–61. https://doi.org/10.5582/irdr.2020.03091
Groft, S.C., Posada De La Paz, M. 2017. Rare diseases: Joining mainstream research and treatment based on reliable epidemiological data. Adv Exp Med Biol 1031: 3–21. https://doi.org/10.1007/978-3-319-67144-4_1
Groft, S.C., Posada, M., Taruscio, D. 2021. Progress, challenges and global approaches to rare diseases. Acta Paediatr 110(10): 2711–2716. https://doi.org/10.1111/apa.15974
Haidle, J.L., Sternen, D.L., Dickerson, J.A., Mroch, A., Needham, D.F., Riordan, C.M., Kieke, M.C. 2017. Genetic counselors save costs across the genetic testing spectrum. Am J Manag Care 23(10 Spec No.): Sp428–Sp430.
Hristova-Atanasova, E., Iskrov, G., Atanasov, I., Genc, A., Stefanov, R. 2023. What is the awareness of rare diseases among medical students? A survey in Bulgaria. Orphanet J Rare Dis 18(1): 213. https://doi.org/10.1186/s13023-023-02820-4
Jamal, M.H., Abdul Aziz, A.F., Aizuddin, A.N., Aljunid, S.M. 2023. Gatekeepers in the health financing scheme: Assessment of knowledge, attitude, practices, and participation of Malaysian private general practitioners in the PeKa B40 scheme. PLoS One 18(10): e0292516. https://doi.org/10.1371/journal.pone.0292516
Kanchan, S., Gaidhane, A. 2023. Social media role and its impact on public health: A narrative review. Cureus 15(1): e33737. https://doi.org/10.7759/cureus.33737
Katakowski, J.A., López, J.C. 2025. Drug development for neglected ultra-rare diseases of no commercial interest: Challenges and opportunities. Drug Discov Today 30(4): 104346. https://doi.org/10.1016/j.drudis.2025.104346
Li, X., Zhang, X., Zhang, S., Lu, Z., Zhang, J., Zhou, J., Li, B., Ou, L. 2021. Rare disease awareness and perspectives of physicians in China: A questionnaire-based study. Orphanet J Rare Dis 16(1): 171. https://doi.org/10.1186/s13023-021-01788-3
Lone, R., Alatoom, A., Nabi, A., Mathur, B., Habou, M., Monga, R., Varghese, R., Daniel, S., Hooda, S.K., Joseph, S., Alhumaidan, H.S.O. 2025. Microbiology laboratory consolidation: Optimising diagnostic efficiency and service quality: A case study from Dubai Health, United Arab Emirates. IJID Reg 17: 100779. https://doi.org/10.1016/j.ijregi.2025.100779
Marwaha, S., Knowles, J.W., Ashley, E.A. 2022. A guide for the diagnosis of rare and undiagnosed disease: Beyond the exome. Genome Med 14(1): 23. https://doi.org/10.1186/s13073-022-01026-w
McCabe, C., Claxton, K., Culyer, A.J. 2008. The NICE cost-effectiveness threshold. Pharmacoeconomics 26(9): 733–744. https://doi.org/10.2165/00019053-200826090-00004
McClendon-Weary, B., Putnick, D.L., Robinson, S., Yeung, E. 2020. Little to give, much to gain: What can you do with a dried blood spot? Curr Environ Health Rep 7(3): 211–221. https://doi.org/10.1007/s40572-020-00289-y
Morgan, G., Subbiah, V. 2023. Rare disease research powered by empowered patients: Solving the zebra puzzle through social media. Cancer 129(14): 2128–2131. https://doi.org/10.1002/cncr.34765
Murdock, L., Taylor & Francis, L., Stephenson, R. 2024. Advancing translational research. J Transl Res 1(1): 2432753. https://doi.org/10.1080/29947448.2024.2432753
Mustapa, F.D., Mustapa, M., Ismail, F., Kherun, N. 2004. Outsourcing in Malaysian healthcare support services: A study on the causes of increased operational costs. Master’s thesis. University College London, London.
Ng, Q.X., Ong, C., Chan, K.E., Ong, T.S.K., Lim, I.J.X., Tang, A.S.P., Chan, H.W., Koh, G.C.H. 2024. Comparative policy analysis of national rare disease funding policies in Australia, Singapore, South Korea, the United Kingdom and the United States: A scoping review. Health Econ Rev 14(1): 42. https://doi.org/10.1186/s13561-024-00519-1
Nguengang Wakap, S., Lambert, D.M., Olry, A., Rodwell, C., Gueydan, C., Lanneau, V., Murphy, D., Le Cam, Y., Rath, A. 2020. Estimating cumulative point prevalence of rare diseases: Analysis of the Orphanet database. Eur J Hum Genet 28(2): 165–173. https://doi.org/10.1038/s41431-019-0508-0
Ormond, K.E., Abad, P.J., Macleod, R., Nishigaki, M., Wessels, T.M. 2024. The global status of genetic counselors in 2023: What has changed in the past 5 years? Genet Med Open 2(Suppl 2): 101887. https://doi.org/10.1016/j.gimo.2024.101887
Patterson, A.M., O’Boyle, M., Vannoy, G.E., Dies, K.A. 2023. Emerging roles and opportunities for rare disease patient advocacy groups. Ther Adv Rare Dis 4: 26330040231164425. https://doi.org/10.1177/26330040231164425
Pop, B., Fetica, B., Blaga, M.L., Trifa, A.P., Achimas-Cadariu, P., Vlad, C.I., Achimas-Cadariu, A. 2019. The role of medical registries, potential applications and limitations. Med Pharm Rep 92(1): 7–14. https://doi.org/10.15386/cjmed-1015
Powell, J., Pring, T. 2024. The impact of social media influencers on health outcomes: Systematic review. Soc Sci Med 340: 116472. https://doi.org/10.1016/j.socscimed.2023.116472
Prince, A.E.R., Uhlmann, W.R., Suter, S.M., Scherer, A.M. 2021. Genetic testing and insurance implications: Surveying the US general population about discrimination concerns and knowledge of the Genetic Information Nondiscrimination Act (GINA). Risk Manag Insur Rev 24(4): 341–365. https://doi.org/10.1111/rmir.12195
Richesson, R., Vehik, K. 2010. Patient registries: Utility, validity and inference. Adv Exp Med Biol 686: 87–104. https://doi.org/10.1007/978-90-481-9485-8_6
Runheim, H., Pettersson, M., Hammarsjö, A., Nordgren, A., Henriksson, M., Lindstrand, A., Levin, L., Soller, M.J. 2023. The cost-effectiveness of whole genome sequencing in neurodevelopmental disorders. Sci Rep 13(1): 6904. https://doi.org/10.1038/s41598-023-33787-8
Saman, J.A., Valinejadi, A., Mohammadi, S., Karimpor, H., Mirzaei, M., Kawyannejad, R. 2020. Assessment of relationship between the use of cell phone and social networks and sleep quality in students of medical sciences: A cross-sectional study. Interv Med Appl Sci 11(3): 131–135. https://doi.org/10.1556/1646.10.2018.30
Shafie, A.A., Chaiyakunapruk, N., Supian, A., Lim, J., Zafra, M., Hassali, M.A.A. 2016. State of rare disease management in Southeast Asia. Orphanet J Rare Dis 11(1): 107. https://doi.org/10.1186/s13023-016-0460-9
Shafie, A.A., Supian, A., Ahmad Hassali, M.A., Ngu, L.H., Thong, M.K., Ayob, H., Chaiyakunapruk, N. 2020. Rare disease in Malaysia: Challenges and solutions. PLoS One 15(4): e0230850. https://doi.org/10.1371/journal.pone.0230850
Shi, Z., Zhang, Q., Wang, X. 2023. Does the disclosure of medical insurance information affect patients’ willingness to adopt the diagnosis-related groups system? Front Public Health 11: 1136178. https://doi.org/10.3389/fpubh.2023.1136178
Sinan, I., Mihdawi, M., Farahat, A.R., Fida, M. 2023. Knowledge and awareness of rare diseases among healthcare professionals in the Kingdom of Bahrain. Cureus 15(10): e47676. https://doi.org/10.7759/cureus.47676
Sohn, E. 2017. Fundraising: The ice bucket challenge delivers. Nature 550(7676): S113–S114. https://doi.org/10.1038/550S113a
Thangiah, G., Said, M.A., Majid, H.A., Reidpath, D., Su, T.T. 2020. Income inequality in quality of life among rural communities in Malaysia: A case for immediate policy consideration. Int J Environ Res Public Health 17(23): 8731. https://doi.org/10.3390/ijerph17238731
Velvin, G., Dammann, B., Haagensen, T., Johansen, H., Strømme, H., Geirdal, A., Bathen, T. 2023. Work participation in adults with rare genetic diseases: A scoping review. BMC Public Health 23(1): 910. https://doi.org/10.1186/s12889-023-15654-3
Willmen, T., Willmen, L., Pankow, A., Ronicke, S., Gabriel, H., Wagner, A.D. 2023. Rare diseases: Why is a rapid referral to an expert center so important? BMC Health Serv Res 23(1): 904. https://doi.org/10.1186/s12913-023-09886-7
Yang, G., Cintina, I., Pariser, A., Oehrlein, E., Sullivan, J., Kennedy, A. 2022. The national economic burden of rare disease in the United States in 2019. Orphanet J Rare Dis 17(1): 163. https://doi.org/10.1186/s13023-022-02299-5
Yoo, H.W. 2024. Development of orphan drugs for rare diseases. Clin Exp Pediatr 67(7): 315–327. https://doi.org/10.3345/cep.2023.00535
Yu, C.P., Whynes, D.K., Sach, T.H. 2008. Equity in health care financing: The case of Malaysia. Int J Equity Health 7(1): 15. https://doi.org/10.1186/1475-9276-7-15
